1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Muscle Spasticity Due to Multiple Sclerosis: new trials by email Literature Review of Muscle Spasticity Due to Multiple Sclerosis trials Research Report on Muscle Spasticity Due to Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis BGG492, Placebo - Muscle Spasticity Due to Multiple Sclerosis | Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2016-10-01 | 2017-04-20 |
Multiple Sclerosis (1) · Muscle Spasticity (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Muscle Hypertonia (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
selurampanel (1)